Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.34 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.34 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.34 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7303318 | 0.90 | NPSR1 (0.41) | NPSR1KDM4CRNASEH1MAPK1LMNA | |
| SCHEMBL1275935 | 0.82 | ALDH1A1 (0.46) | NPSR1HPGDMAPK1LMNAKMT2A | |
| SCHEMBL7398766 | 0.82 | HPGD (0.37) | NPSR1KDM4CHPGDMAPK1LMNA | |
| SCHEMBL9199916 | 0.82 | HPGD (0.46) | NPSR1KDM4CHPGDMAPK1LMNA | |
| SCHEMBL29109938 | 0.81 | LMNA (0.42) | NPSR1KDM4CRNASEH1MAPK1LMNA | |
| SCHEMBL23930812 | 0.81 | NPSR1 (0.45) | NPSR1KDM4CRNASEH1LMNARAB9A | |
| Hydrochloric Acid SCHEMBL1417761 | 0.81 | ALDH1A1 (0.45) | NPSR1HPGDMAPK1LMNAKMT2A | |
| SCHEMBL30663426 | 0.81 | NPSR1 (0.41) | NPSR1KDM4CRNASEH1HPGDMAPK1 | |
| Hydrochloric Acid SCHEMBL7883592 | 0.80 | NPSR1 (0.44) | NPSR1KDM4CRNASEH1MAPK1LMNA | |
| SCHEMBL2121837 | 0.78 | HCRTR1 (0.35) | NPSR1KDM4CHPGDMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011007368-A2 | AN IMPROVED PROCESS FOR PREPARATION OF OLMESARTAN | CADILA HEALTHCARE LIMITED (IN) | 2011-01-20 | — | — | WO | disclosed |
| WO-2007047838-A2 | PROCESS FOR PREPARING OLMESARTAN MEDOXOMIL | DR. REDDY'S LABORATORIES LTD. (IN) | 2007-04-26 | — | — | WO | disclosed |
| WO-2007047838-A2 | PROCESS FOR PREPARING OLMESARTAN MEDOXOMIL | DR. REDDY'S LABORATORIES LTD. (IN) | 2007-04-26 | — | — | WO | disclosed |
| EP-0733366-B1 | Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics | DU PONT (US) | 1998-04-01 | — | — | EP | disclosed |
| EP-0324377-B1 | Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids | DU PONT (US) | 1997-04-16 | — | — | EP | disclosed |
| EP-0733366-A2 | Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-09-25 | — | — | EP | disclosed |
| EP-0479903-B1 | SUBSTITUTED IMIDAZOLES USEFUL AS ANGIOTENSIN II BLOCKERS | DU PONT (US) | 1996-02-21 | — | — | EP | disclosed |
| US-5389635-A | 4- or 5-heterocyclic substituted imadazoles as angiotensin-II antagonists | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-02-14 | — | — | US | disclosed |
| US-5354867-A | Hypertensive agents; congestive heart failure; used with diuretics to enhance activity; used with NSAIDs to prevent renal failure | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-10-11 | — | — | US | disclosed |
| US-5254546-A | Hypotensive agent | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-10-19 | — | — | US | disclosed |
| US-5155118-A | Administering angiotensin inhibitor | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-10-13 | — | — | US | disclosed |
| US-5153197-A | Treatment of hypertension with angiotensin II blocking imidazoles | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-10-06 | — | — | US | disclosed |
| US-5138069-A | Treating hypertension and congestive heart failure | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-08-11 | — | — | US | disclosed |
| US-5128355-A | Hypotensive | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-07-07 | — | — | US | disclosed |
| EP-0479892-A1 | FUSED-RING ARYL SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-15 | — | — | EP | disclosed |
| EP-0479903-A1 | SUBSTITUTED IMIDAZOLES. | DU PONT (US) | 1992-04-15 | — | — | EP | disclosed |
| WO-1991000277-A1 | SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-10 | — | — | WO | disclosed |
| WO-1991000281-A2 | FUSED-RING ARYL SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-10 | — | — | WO | disclosed |
| EP-0324377-A2 | Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-07-19 | — | — | EP | disclosed |
| WO-1989006233-A1 | ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLES AND COMBINATIONS THEREOF WITH DIURETICS AND NSAIDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-07-13 | — | — | WO | disclosed |